UNICREDIT BANK/CALL/NOVO-NORDISK B/750/0.2/18.12.24 Stock

Warrant

DE000HC7P3B3

Market Closed - BOERSE MUENCHEN 15:45:17 2024-05-31 EDT
5.51 EUR +0.92% Intraday chart for UNICREDIT BANK/CALL/NOVO-NORDISK B/750/0.2/18.12.24
1 month+6.58%
3 months+49.32%
Date Price Change
24-05-31 5.51 +0.92%
24-05-30 5.46 +2.25%
24-05-29 5.34 -2.02%
24-05-28 5.45 -1.27%
24-05-27 5.52 -6.28%

Real-time BOERSE MUENCHEN

Last update May 31, 2024 at 03:45 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying NOVO NORDISK A/S
IssuerLogo Issuer UniCredit UniCredit
WKN HC7P3B
ISINDE000HC7P3B3
Date issued 2023-06-26
Strike 750 kr
Maturity 2024-12-18 (199 Days)
Parity 5 : 1
Emission price 0.78
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 6.04
Lowest since issue 0.55
Delta0x
Omega 0.000000
Premium0x
Gearing4.41x
Moneyness 1.236
Difference Strike -177.3 kr
Difference Strike %-23.64%
Spread 0.12
Spread %2.11%
Intrinsic value 4.750
Present value 0.8805

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
927.3 DKK
Average target price
917.2 DKK
Spread / Average Target
-1.09%
Consensus